World Hepatitis Day: Quiet Science, Real People

Every year, World Hepatitis Day serves as a stark reminder: hepatitis B and C often go undetected for years, silently progressing toward liver damage, cirrhosis, or cancer. Millions live with this threat while thousands of scientists continue the quiet fight in labs — analyzing data, probing cells, and chasing solutions.

The numbers don’t lie, 1.3 million people lose their lives to hepatitis due to lack of testing, treatment, or vaccination. With deaths rising, the world must act now to meet the 2030 elimination goal. This World Hepatitis Day, the global community call is clear: increase resources, ensure access to care, and accelerate progress.

At AcceGen, we are part of that fight! We support by providing validated liver disease models — not just as research tools, but as critical pieces of a larger mission: a shared responsibility to help move science forward.

The Right Tools for the Fight

We provide a range of human liver cancer cell lines critical for hepatitis research, including Hep 3B2.17, which carries integrated HBV genome and expresses HBsAg; HuH7 widely used for HBV and HCV studies with extensive literature support; PLC/PRF/5 expressing HBsAg and integrated HBV genome for pathology and antiviral screening, which makes them a gold standard for HBV and HCV research; the official Hep 3B line suitable for virus-related cancer and drug testing; and the HuH7 Luciferase Reporter cell line equipped with a luciferase system ideal for rapid drug screening and dynamic analysis of HBV/HCV infection pathways, particularly useful in promotional activities and scientific communication.

They are not here to impress.
They are here to deliver — quietly, steadily, every single day.
Just like the researchers who rely on them.

Behind the Science, Real Persistence!

Behind every experiment is a scientist repeating controls at midnight.
Behind every publication is a team debating over unexpected results.
And behind every assay is the understanding that this work might contribute — however small—might lead to better outcomes, earlier diagnoses, or safer treatments.

That is what keeps us going.
Not the speed. Not the scale.
But the simple belief that the tools we offer could make someone’s research easier — and someone’s life longer.

This World Hepatitis Day, we stand with the scientists, students, clinicians, and patients who keep asking the hard questions — and quietly working toward answers.

Explore our cell models for HBV and HCV research.
Quiet tools, real impact.